These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12689696)

  • 1. Characteristic developmental expression of amyloid beta40, 42 and 43 in patients with Down syndrome.
    Hirayama A; Horikoshi Y; Maeda M; Ito M; Takashima S
    Brain Dev; 2003 Apr; 25(3):180-5. PubMed ID: 12689696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains.
    Arai Y; Suzuki A; Mizuguchi M; Takashima S
    Brain Dev; 1997 Jun; 19(4):290-4. PubMed ID: 9187481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of amyloid precursor protein in senile plaques in the brain of a patient with Alzheimer-type dementia and Down syndrome.
    Arai Y; Iwasaki Y; Suzuki T; Ide S; Kaga M
    Brain Dev; 2019 Jan; 41(1):106-110. PubMed ID: 30086988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits.
    Kowa H; Sakakura T; Matsuura Y; Wakabayashi T; Mann DM; Duff K; Tsuji S; Hashimoto T; Iwatsubo T
    Am J Pathol; 2004 Jul; 165(1):273-81. PubMed ID: 15215182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome.
    Teller JK; Russo C; DeBusk LM; Angelini G; Zaccheo D; Dagna-Bricarelli F; Scartezzini P; Bertolini S; Mann DM; Tabaton M; Gambetti P
    Nat Med; 1996 Jan; 2(1):93-5. PubMed ID: 8564851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental immunohistochemistry of growth inhibitory factor in normal brains and brains of patients with Down syndrome.
    Arai Y; Uchida Y; Takashima S
    Pediatr Neurol; 1997 Sep; 17(2):134-8. PubMed ID: 9367293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan.
    LeVine H; Spielmann HP; Matveev S; Cauvi FM; Murphy MP; Beckett TL; McCarty K; Lott IT; Doran E; Schmitt F; Head E
    Neurobiol Aging; 2017 Jun; 54():163-169. PubMed ID: 28385551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The developmental and aging changes of Down's syndrome cell adhesion molecule expression in normal and Down's syndrome brains.
    Saito Y; Oka A; Mizuguchi M; Motonaga K; Mori Y; Becker LE; Arima K; Miyauchi J; Takashima S
    Acta Neuropathol; 2000 Dec; 100(6):654-64. PubMed ID: 11078217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
    Cras P; Kawai M; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7552-6. PubMed ID: 1652752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
    Cheon MS; Dierssen M; Kim SH; Lubec G
    Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraneuronal Abeta42 accumulation in Down syndrome brain.
    Mori C; Spooner ET; Wisniewsk KE; Wisniewski TM; Yamaguch H; Saido TC; Tolan DR; Selkoe DJ; Lemere CA
    Amyloid; 2002 Jun; 9(2):88-102. PubMed ID: 12440481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental changes of apolipoprotein E immunoreactivity in Down syndrome brains.
    Arai Y; Mizuguchi M; Ikeda K; Takashima S
    Brain Res Dev Brain Res; 1995 Jul; 87(2):228-32. PubMed ID: 7586507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraneuronal Abeta42 accumulation in human brain.
    Gouras GK; Tsai J; Naslund J; Vincent B; Edgar M; Checler F; Greenfield JP; Haroutunian V; Buxbaum JD; Xu H; Greengard P; Relkin NR
    Am J Pathol; 2000 Jan; 156(1):15-20. PubMed ID: 10623648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome.
    Busciglio J; Pelsman A; Wong C; Pigino G; Yuan M; Mori H; Yankner BA
    Neuron; 2002 Feb; 33(5):677-88. PubMed ID: 11879646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
    Mehta PD; Capone G; Jewell A; Freedland RL
    J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression on Kunitz-type protease inhibitor-containing substances in the cerebral vessels of patients with Down syndrome.
    Suzuki A; Takashima S; Mizuguchi M; Kato M; Kunishita T; Tabira T
    Tohoku J Exp Med; 1994 Nov; 174(3):181-7. PubMed ID: 7761983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
    Zou K; Liu J; Watanabe A; Hiraga S; Liu S; Tanabe C; Maeda T; Terayama Y; Takahashi S; Michikawa M; Komano H
    Am J Pathol; 2013 Jun; 182(6):2322-31. PubMed ID: 23562443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species.
    López-González I; Schlüter A; Aso E; Garcia-Esparcia P; Ansoleaga B; LLorens F; Carmona M; Moreno J; Fuso A; Portero-Otin M; Pamplona R; Pujol A; Ferrer I
    J Neuropathol Exp Neurol; 2015 Apr; 74(4):319-44. PubMed ID: 25756590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.